Cited by 59MicroRNA in disease regulationUrinary Bladder and Prostate ResearchBladder and Urothelial Cancer Treatments

miR-199a-5p Regulates Urothelial Permeability and May Play a Role in Bladder Pain Syndrome

Open access
Monastyrskaya, Katia, Sánchez-Freire, Verónica, Hashemi Gheinani, Ali, Klumpp, David J., Babiychuk, Eduard B., Draeger, Annette, Burkhard, Fiona C.·2013·The American Journal of Pathology

Abstract

Defects in urothelial integrity resulting in leakage and activation of underlying sensory nerves are potential causative factors of bladder pain syndrome, a clinical syndrome of pelvic pain and urinary urgency/frequency in the absence of a specific cause. Herein, we identified the microRNA miR-199a-5p as an important regulator of intercellular junctions. On overexpression in urothelial cells, it impairs correct tight junction formation and leads to increased permeability. miR-199a-5p directly targets mRNAs encoding LIN7C, ARHGAP12, PALS1, RND1, and PVRL1 and attenuates their expression levels to a similar extent. Using laser microdissection, we showed that miR-199a-5p is predominantly expressed in bladder smooth muscle but that it is also detected in mature bladder urothelium and primary urothelial cultures. In the urothelium, its expression can be up-regulated after activation of cAMP signaling pathways. While validating miR-199a-5p targets, we delineated novel functions of LIN7C and ARHGAP12 in urothelial integrity and confirmed the essential role of PALS1 in establishing and maintaining urothelial polarity and junction assembly. The present results point to a possible link between miR-199a-5p expression and the control of urothelial permeability in bladder pain syndrome. Up-regulation of miR-199a-5p and concomitant down-regulation of its multiple targets might be detrimental to the establishment of a tight urothelial barrier, leading to chronic pain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2012.10.020

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Knocking out LIN7C had a more severe reduction on growth in KRAS G13D cell lines compared to the others.

    “knocking out LIN7C, a gene that maintains the asymmetric distribution of membrane proteins in polarized epithelial cells67, had a more severe reduction on growth in KRAS G13D cell lines compared to the others”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 57 · Cited by 59

Authors
Monastyrskaya, K., Sánchez-Freire, V., Hashemi Gheinani, A., Klumpp, D. J., Babiychuk, E. B., Draeger, A., & Burkhard, F. C.
Affiliations
  • University of Bern (CH)
  • Stanford Medicine (US)
  • Northwestern University (US)
Corresponding author
Monastyrskaya, Katia
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2013-02
Volume
182
Issue
2
Pages
431-448
ISSN
0002-9440 (ISSN-L)
OpenAlex
W1990851739
Cited by
59
References
57
Citations by year
2026: 3 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 11 · 2014: 4 · 2013: 5
FWCI
2.12
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Funders
  • Universität Bern
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3100A0_121980/1, 320030_128064, 320030_135783/1, PBBEP3_129803)
  • Bernische Krebsliga
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
Keywords
miR-199a-5p, interstitial cystitis, urothelial permeability, tight junctions, PALS1, Rnd1, cAMP signaling, bladder smooth muscle, miRNA target genes, chronic pelvic pain
MeSH terms
Cyclic AMP, Base Sequence, Binding Sites, Urinary Bladder, Cell Differentiation, Cell Line, Epithelial Cells, Humans, Luciferases, Molecular Sequence Data, Muscle, Smooth, Permeability, Protein Binding, RNA, Messenger, Down-Regulation, Up-Regulation, Electric Impedance, Cystitis, Interstitial, Urothelium, 3' Untranslated Regions, rhoA GTP-Binding Protein, rac1 GTP-Binding Protein, RNA, Small Interfering, MicroRNAs, Tight Junction Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review